eMedicine Specialties > Nephrology > Acute Kidney Failure

Acute Tubular Necrosis: Differential Diagnoses & Workup

Author: Edgar V Lerma, MD, Clinical Associate Professor of Medicine, Section of Nephrology, Department of Medicine, University of Illinois at Chicago College of Medicine; Consulting Staff, Associates in Nephrology, SC
Coauthor(s): Brent Kelly, MD, Resident Physician, Department of Internal Medicine, University of Texas Medical Branch School of Medicine; Mahendra Agraharkar, MD, MBBS, FACP, FASN, Clinical Associate Professor of Medicine, Baylor College of Medicine, President & CEO, Space City Associates of Nephrology
Contributor Information and Disclosures

Updated: Aug 28, 2009

Differential Diagnoses

Acute Renal Failure
Azotemia
Chronic Renal Failure
Glomerulonephritis, Acute
Nephritis, Interstitial

Other Problems to Be Considered

Prerenal azotemia
Acute interstitial nephritis
Renal vasculitis
Obstructive uropathy

Workup

Laboratory Studies

Serum chemistries: By definition, BUN and serum creatinine concentrations are increased in ARF. In addition, hyponatremia, hyperkalemia, hypermagnesemia, hypocalcemia, and hyperphosphatemia may be present. A metabolic acidosis is also found. Remember that hypercalcemia and hyperuricemia may suggest a malignant condition as a cause.

CBC count: CBC count may reveal anemia. Erythropoietin production is decreased in ARF, and dysfunctional platelets (from uremia) also make bleeding more likely.

Urinalysis: The centrifuged sediment of urine is particularly helpful because it may reveal pigmented, muddy brown, granular casts, suggesting that established ATN is present. However, remember that these casts may be absent in 20-30% of patients with ATN. In addition to the routine urinalysis, urine electrolytes may also help differentiate ATN from prerenal azotemia. The urinary sediment, electrolyte, and osmolality findings that can help to separate ATN from prerenal azotemia are illustrated in the following Table.

Laboratory Findings Used to Differentiate Prerenal Azotemia From ATN

Open table in new window

Table
FindingPrerenal AzotemiaATN and/or Intrinsic Renal Disease
Urine osmolarity
(mOsm/kg)
>500<350
Urine sodium
(mmol/d)
<20>40
Fractional excretion of sodium
(%)
<1> 2
Fractional excretion of urea
(%)
<35>50
Urine sedimentBland and/or nonspecificMay show muddy brown granular casts
FindingPrerenal AzotemiaATN and/or Intrinsic Renal Disease
Urine osmolarity
(mOsm/kg)
>500<350
Urine sodium
(mmol/d)
<20>40
Fractional excretion of sodium
(%)
<1> 2
Fractional excretion of urea
(%)
<35>50
Urine sedimentBland and/or nonspecificMay show muddy brown granular casts


Fractional excretion of a substance is calculated by the formula (U/P)z/(U/P)Cr X 100, where z is the substance, U and P represent urine and plasma concentrations, and Cr stands for creatinine.

Imaging Studies

  • An abdominal radiograph is of limited benefit in ARF, with the exception of diagnosing (or helping to exclude) nephrolithiasis.
  • Ultrasonography, computed tomography (CT) scanning, and MRI are extremely useful to exclude obstructive uropathy and to measure renal size and cortical thickness. Renal ultrasonography is a simple procedure that should be undertaken in all patients who present with ARF.

Procedures

  • Biopsy is rarely necessary. It should be performed only when the exact renal cause of ARF is unclear and the course is protracted. Prerenal and postrenal causes must be ruled out first. The diagnosis of ATN is made on a clinical basis, that is, with the help of a detailed and accurate history, a thorough physical examination, and pertinent laboratory examinations and imaging studies. A more urgent indication for renal biopsy is in the setting of clinical and urinary findings that suggest renal vasculitis rather than ATN; the diagnosis needs to be established quickly so that appropriate immunomodulatory therapy can be initiated. The biopsy is performed under ultrasound or CT scan guidance after ascertaining the safety of the procedure. A biopsy may also be more critically important in the setting of a renal transplant patient to rule out rejection.17,18

Histologic Findings

In most circumstances, the histology demonstrates the loss of tubular cells or the denuded tubules. As illustrated in the image below and in Image 1, the tubular cells reveal swelling, formation of blebs over the cellular surface, and exfoliation of the tubular cells into the lumina. The earliest finding could be loss of the cellular brush border. (See also images below and Images 2-5.)

A photomicrograph of renal biopsy shows renal med...

A photomicrograph of renal biopsy shows renal medulla, which is composed mainly of renal tubules. Patchy or diffuse denudation of the renal tubular cells is observed, suggesting acute tubular necrosis (ATN) as the cause of acute renal failure (ARF).

A photomicrograph of renal biopsy shows renal med...

A photomicrograph of renal biopsy shows renal medulla, which is composed mainly of renal tubules. Patchy or diffuse denudation of the renal tubular cells is observed, suggesting acute tubular necrosis (ATN) as the cause of acute renal failure (ARF).



Acute tubular necrosis (ATN). Flattening of the r...

Acute tubular necrosis (ATN). Flattening of the renal tubule cells due to tubular dilation.

Acute tubular necrosis (ATN). Flattening of the r...

Acute tubular necrosis (ATN). Flattening of the renal tubule cells due to tubular dilation.



Acute tubular necrosis. Intratubular cast formati...

Acute tubular necrosis. Intratubular cast formation.

Acute tubular necrosis. Intratubular cast formati...

Acute tubular necrosis. Intratubular cast formation.



Acute tubular necrosis. Intratubular obstruction ...

Acute tubular necrosis. Intratubular obstruction due to the denuded epithelium and cellular debris. Note that the denuded tubular epithelial cells clump together due to rearrangement of intercellular adhesion molecules (ICAM).

Acute tubular necrosis. Intratubular obstruction ...

Acute tubular necrosis. Intratubular obstruction due to the denuded epithelium and cellular debris. Note that the denuded tubular epithelial cells clump together due to rearrangement of intercellular adhesion molecules (ICAM).



Sloughing of cells, which is responsible for the ...

Sloughing of cells, which is responsible for the formation of granular casts, a feature of acute tubular necrosis (ATN).

Sloughing of cells, which is responsible for the ...

Sloughing of cells, which is responsible for the formation of granular casts, a feature of acute tubular necrosis (ATN).

More on Acute Tubular Necrosis

Overview: Acute Tubular Necrosis
Differential Diagnoses & Workup: Acute Tubular Necrosis
Treatment & Medication: Acute Tubular Necrosis
Follow-up: Acute Tubular Necrosis
Multimedia: Acute Tubular Necrosis
References
Further Reading

References

  1. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. Aug 2004;8(4):R204-12. [Medline][Full Text].

  2. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. [Medline][Full Text].

  3. Mehta R, Kellum JA, Levin A. From acute renal failure to acute kidney injury: what's changed?. Nephrology Self-Assessment Program. 2007;6(5):281.

  4. Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol. 2007;156:203-12. [Medline].

  5. Mishra J, Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. Dec 2004;15(12):3073-82. [Medline].

  6. Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. Jun 2006;21(6):856-63. [Medline].

  7. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. Apr 2-8 2005;365(9466):1231-8. [Medline].

  8. Dent CL, Ma Q, Dastrala S, et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care. 2007;11(6):R127. [Medline].

  9. Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. Dec 2007;22(12):2089-95. [Medline].

  10. Wagener G, Jan M, Kim M, et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. Sep 2006;105(3):485-91. [Medline].

  11. Zhou H, Hewitt SM, Yuen PS, et al. Acute kidney injury biomarkers - needs, present status, and future promise. Nephrol Self Assess Program. Mar 2006;5(2):63-71. [Medline].

  12. Parikh CR, Jani A, Melnikov VY, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. Mar 2004;43(3):405-14. [Medline].

  13. Han WK, Bailly V, Abichandani R, et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. Jul 2002;62(1):237-44. [Medline].

  14. van Timmeren MM, Vaidya VS, van Ree RM, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation. Dec 27 2007;84(12):1625-30. [Medline].

  15. du Cheyron D, Daubin C, Poggioli J, et al. Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis. Sep 2003;42(3):497-506. [Medline].

  16. Verghese E, Ricardo SD, Weidenfeld R, et al. Renal primary cilia lengthen after acute tubular necrosis. J Am Soc Nephrol. Jul 16 2009;[Medline].

  17. Perdiz LB, Furtado GH, Linhares MM, et al. Incidence and risk factors for surgical site infection after simultaneous pancreas-kidney transplantation. J Hosp Infect. Aug 2009;72(4):326-31. [Medline].

  18. Mattoso R, Khouri N, de Jesus L, et al. Risk factors for graft dysfunction in the late period of renal transplantation. Transplant Proc. Jun 2009;41(5):1594-8. [Medline].

  19. Fauci A, Hauser SL. Acute renal failure. In: Harrison's Principles of Internal Medicine. 14th ed. New York, NY:. McGraw-Hill;1998:1505-7.

  20. Klahr S, Miller SB. Acute oliguria. N Engl J Med. Mar 5 1998;338(10):671-5. [Medline].

  21. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. May 19 2004;291(19):2328-34. [Medline].

  22. Mishra J, Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. Dec 2004;15(12):3073-82. [Medline].

  23. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. Feb 11 2002;162(3):329-36. [Medline].

  24. Schrier R, Gottschalk C. Acute renal failure. In: Diseases of the Kidney. 6th ed. Philadelphia, Pa:. Lippincott, Williams and Wilkins;1997:1013-302.

  25. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. Jul 20 2000;343(3):180-4. [Medline].

  26. Thadhani R, Pascual M, Bonventre JV. Acute Renal Failure. New Engl J Med. 1996;338 (10):1448-1457. [Medline].

  27. Tierney L, McPhee S, Papadakis M. Acute renal failure In: Current Medical Diagnosis & Treatment. New York, NY:. McGraw-Hill;1998:853-7.

Further Reading

Related eMedicine topics:
Acute Renal Failure
Acute Tubular Necrosis [Pediatrics: General Medicine]
Azotemia
Kidney Transplantation, Surgical Complications
Kidney, Trauma
Oliguria
Renal Failure, Acute

Clinical guidelines:
ACR Appropriateness Criteria® renal failure. American College of Radiology - Medical Specialty Society.  1995 (revised 2005).  8 pages. [NGC Update Pending] NGC:004615

Clinical trials:
Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery

Sensitivity and Specificity of NGAL in an Emergency Room Population

Keywords

acute tubular necrosis, renal failure, kidney failure, acute renal failure, tubular necrosis, end-stage renal disease, acute kidney failure, intrinsic renal disease, acute ischemic nephropathy, ischemic acute tubular necrosis, nephrotoxic acute tubular necrosis

Contributor Information and Disclosures

Author

Edgar V Lerma, MD, Clinical Associate Professor of Medicine, Section of Nephrology, Department of Medicine, University of Illinois at Chicago College of Medicine; Consulting Staff, Associates in Nephrology, SC
Edgar V Lerma, MD is a member of the following medical societies: American Heart Association, American Medical Association, American Society of Hypertension, American Society of Nephrology, Chicago Medical Society, Illinois State Medical Society, National Kidney Foundation, and Society of General Internal Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Brent Kelly, MD, Resident Physician, Department of Internal Medicine, University of Texas Medical Branch School of Medicine
Brent Kelly, MD is a member of the following medical societies: Alpha Omega Alpha and American Medical Association
Disclosure: Nothing to disclose.

Mahendra Agraharkar, MD, MBBS, FACP, FASN, Clinical Associate Professor of Medicine, Baylor College of Medicine, President & CEO, Space City Associates of Nephrology
Mahendra Agraharkar, MD, MBBS, FACP, FASN is a member of the following medical societies: American College of Physicians, American Society of Nephrology, and National Kidney Foundation
Disclosure: South Shore DaVita Dialysis Center  Ownership interest Other

Medical Editor

F John Gennari, MD, Associate Chair for Academic Affairs, Robert F and Genevieve B Patrick Professor, Department of Medicine, University of Vermont College of Medicine
F John Gennari, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, American Federation for Medical Research, American Heart Association, American Physiological Society, American Society for Clinical Investigation, American Society of Nephrology, and International Society of Nephrology
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

George R Aronoff, MD, Director, Professor, Departments of Internal Medicine and Pharmacology, Section of Nephrology, Kidney Disease Program, University of Louisville School of Medicine
George R Aronoff, MD is a member of the following medical societies: American Federation for Medical Research, American Society of Nephrology, Kentucky Medical Association, and National Kidney Foundation
Disclosure: Nothing to disclose.

CME Editor

Rebecca J Schmidt, DO, FACP, FASN, Professor of Medicine, Section Chief, Department of Medicine, Section of Nephrology, West Virginia University School of Medicine
Rebecca J Schmidt, DO, FACP, FASN is a member of the following medical societies: American College of Osteopathic Internists, American College of Physicians, American Medical Association, American Society of Nephrology, International Society of Nephrology, National Kidney Foundation, Renal Physicians Association, and West Virginia State Medical Association
Disclosure: Abbott Grant/research funds Speaking and teaching; Genzyme Honoraria Consulting; Amgen Honoraria Speaking and teaching; Ortho Biotech Honoraria Speaking and teaching

Chief Editor

Vecihi Batuman, MD, FACP, FASN, Professor of Medicine, Section of Nephrology-Hypertension, Tulane University School of Medicine; Chief, Medicine Service, Southeast Louisiana Veterans Health Care System
Vecihi Batuman, MD, FACP, FASN is a member of the following medical societies: American College of Physicians, American Society of Hypertension, American Society of Nephrology, and International Society of Nephrology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.